Nautilus Biotechnology, Inc. Retained Earnings
Nautilus Biotechnology, Inc. (NAUT) had Retained Earnings of -$361.19 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-28
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$361.19M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$346.72M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$332.02M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$318.24M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$361.19M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | -$346.72M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | -$332.02M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | -$318.24M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | -$304.67M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | -$289.63M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | -$273.02M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$255.43M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | -$238.98M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | -$220.97M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | -$202.24M 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$185.22M 10-Q · filed 2023-10-31 | |
| 2023-06-30 | -$169.34M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | -$153.53M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | -$138.56M 10-K · filed 2024-02-28 | |
| 2022-09-30 | -$125.16M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | -$111.09M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | -$96.40M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | -$80.64M 10-K · filed 2023-02-23 | |
| 2021-09-30 | -$63.95M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | -$49.45M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | -$2.29M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$30.32M 10-K · filed 2022-02-24 | -$523.08K 10-K · filed 2021-03-30 |
| 2020-09-30 | -$170.71K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | -$11.72K 10-Q · filed 2020-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |